{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:10:12Z","timestamp":1789989012076,"version":"4.0.1"},"reference-count":28,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.2967\/jnumed.113.130005","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T04:22:55Z","timestamp":1393561375000},"page":"574-581","source":"Crossref","is-referenced-by-count":75,"title":["Impact of <sup>18<\/sup>F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry"],"prefix":"10.2967","volume":"55","author":[{"given":"Bruce E.","family":"Hillner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghai","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony F.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Edward","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"key":"2021051712060681000_55.4.574.1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0027"},{"key":"2021051712060681000_55.4.574.2","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0b013e328361d451"},{"key":"2021051712060681000_55.4.574.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.037200"},{"key":"2021051712060681000_55.4.574.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.09.053"},{"key":"2021051712060681000_55.4.574.5","unstructured":"Sodium fluoride F 18 injection investigator's brochure. National Cancer Institute. Release Date August 2008. http:\/\/imaging.cancer.gov\/images\/documents\/Generic-NaF_IB_ed.1_10-2009.pdf. Accessed February 5, 2014."},{"key":"2021051712060681000_55.4.574.6","unstructured":"NCA for Positron Emission Tomography. (NaF-18) to identify bone metastasis of cancer (CAG-00065R). CMS.gov. http:\/\/www.cms.gov\/mcd\/viewnca.asp?from=ncd&nca_id=233. Accessed February 5, 2014."},{"key":"2021051712060681000_55.4.574.7","unstructured":"National coverage determinations with data collection as a condition of coverage: coverage with evidence development. Centers for Medicare & Medicaid Services. http:\/\/www.cms.hhs.gov\/Transmittals\/downloads\/R956CP.pdf. Accessed February 5, 2014."},{"key":"2021051712060681000_55.4.574.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2009.01.016"},{"key":"2021051712060681000_55.4.574.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.043687"},{"key":"2021051712060681000_55.4.574.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.5631"},{"key":"2021051712060681000_55.4.574.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.056713"},{"key":"2021051712060681000_55.4.574.12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24000"},{"key":"2021051712060681000_55.4.574.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.103911"},{"key":"2021051712060681000_55.4.574.14","unstructured":"Agresti A . Categorical Data Analysis. 3rd ed. Hoboken, NJ: Wiley-Interscience; 2013."},{"key":"2021051712060681000_55.4.574.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2361-7"},{"key":"2021051712060681000_55.4.574.16","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712060681000_55.4.574.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.082263"},{"key":"2021051712060681000_55.4.574.18","unstructured":"Lofgren J Mortensen J Loft A . Diagnosing bone metastases: pilot data from a prospective study comparing [99mTc]-MDP planar bone scintigraphy, whole body SPECT\/CT, [18F]-fluoride PET\/CT and [18F]-fluoride PET\/MRI. J Nucl Med. 2013;54(suppl 2):93."},{"key":"2021051712060681000_55.4.574.19","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-013-0179-7"},{"key":"2021051712060681000_55.4.574.20","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-010-0393-7"},{"key":"2021051712060681000_55.4.574.21","doi-asserted-by":"crossref","first-page":"S-1","DOI":"10.6004\/jnccn.2013.0215","article-title":"NCCN Task Force report: bone health in cancer care","volume":"11","author":"Gralow","year":"2013","journal-title":"J Natl Compr Canc Netw."},{"key":"2021051712060681000_55.4.574.22","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26416"},{"key":"2021051712060681000_55.4.574.23","unstructured":"Moul J Lee J . Rising serum PSA following local therapy for prostate cancer: diagnostic evaluation. http:\/\/www.uptodate.com\/contents\/rising-serum-psa-following-local-therapy-for-prostate-cancer-definition-natural-history-and-risk-stratification?source=search_result&search=rising+PSA&selectedTitle=1%7E29. Accessed February 19, 2014."},{"key":"2021051712060681000_55.4.574.24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.6004\/jnccn.2012.0114","article-title":"Prostate cancer, version 3.2012: featured updates to the NCCN guidelines","volume":"10","author":"Mohler","year":"2012","journal-title":"J Natl Compr Canc Netw."},{"key":"2021051712060681000_55.4.574.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2013.04.010"},{"key":"2021051712060681000_55.4.574.26","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318287d860"},{"key":"2021051712060681000_55.4.574.27","doi-asserted-by":"crossref","unstructured":"Hillner BE Tosteson TD Tosteson AN . Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry. J Nucl Med. 2013;54:2024\u20132031.","DOI":"10.2967\/jnumed.113.123430"},{"key":"2021051712060681000_55.4.574.28","unstructured":"F18PET\/CT versus TC-MDP scanning to detect bone mets. Clinical Trials.gov NCT 00882609. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00882609?term=sodium+fluoride+PET&phase=2&rank=2. Accessed February 19, 2014."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.113.130005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:54:59Z","timestamp":1621281299000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.113.130005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,1]]},"published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.2967\/jnumed.113.130005"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.113.130005","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,27]]}}}